The Future of Pharma Field Force: Engaging healthcare providers through peer-to-peer education 

With an unprecedented number of drug launches, the need for field force engagement has never been greater – but it’s the right type of engagement that matters. Field reps often perceive that providers want them to identify patient opportunities with new therapies, but a recent study by Bain & Company found that providers actually want their reps to provide trend data, patient support, and introductions to top experts in their field.  […]

Read More

CME Programs Increases Competency in Managing Neuroendocrine Tumors

Targeted therapies have allowed for better management of neuroendocrine tumors (NETs), yet this requires that healthcare providers glean new knowledge about treatment options such as somatostatin analogs. To improve provider competency and include consideration of patient perspectives in treatment selection, PlatformQ Health and Healing NET Foundation teamed up with the Moffitt Cancer Center to produce a free educational initiative for providers. […]

Read More

PlatformQ Health Presents Health Outcomes in Myelodysplastic Syndrome and Ulcerative Colitis at BMS Poster Day 2022

PlatformQ Health was invited to present at Bristol Myers Squibb private poster day. The posters present outcomes from two educational initiatives that show positive improvements in patient experience and clinical practice. CME Education Improves Clinical Practice for Treating Ulcerative Colitis Recent changes in understanding the drivers of ulcerative colitis have changed how the disease is […]

Read More

51st CNS Annual Meeting: Presenting Educational Outcomes on Aligning Patient/Caregiver Roles in Developmental and Epileptic Encephalopathies

The management of developmental and epileptic encephalopathies (DEEs) has shifted in recent years, necessitating changes in treatment decisions. In the wake of these changes, PlatformQ Health, the National Organization for Rare Disorders, the Lennox Gastaut Syndrome Foundation, and the University of California, San Francisco came together to produce aligned, online continuing education to support healthcare providers in their ability to diagnose and treat DEEs and help caregivers to engage in care. […]

Read More

CancerCare, BlackDoctor.org, and TOUCH: The Black Breast Cancer Alliance Collaborate with PlatformQ Health to Promote Diversity in Breast and Lung Cancer Clinical Trials

People of color, the elderly, as well as those living in rural areas are disproportionately affected by cancer, yet are severely underrepresented in cancer clinical trials. The lack of diversity in clinical trials leaves these patients at a severe disadvantage because there is little insight into the safety and effectiveness of therapies for them. […]

Read More

Breaking Down Barriers Between Patients & Providers

When confronting a frightening condition like bladder cancer, patients may fall into a rabbit hole of information online. It can be challenging to discern what sites to trust and where to turn. Not only are patients facing concerns about their own survival, but also worries over sensitive issues such as bladder function and sexual health. In this situation, it can be difficult for patients to open up to providers about their fears. […]

Read More

All Together Now for Cancer Clinical Trials

Inclusive clinical trials enable more patients to benefit from therapies that can improve their quality of life. However, an under-representation of racial and ethnic minority groups in clinical trials has been, and continues to be, a major issue within the U.S. healthcare system. “Disparities in clinical research participation are well documented and, like many other […]

Read More

The Future of Cell and Gene Therapy

Cell and gene therapies are transforming the course of disease treatment, from gene replacement that extends the lives of infants with spinal muscular atrophy, to CAR T-cell therapies that bring durable remission to patients with difficult-to-treat blood cancers. […]

Read More

Genetic Mitochondrial Disease: Live and On-demand CME Programs Close Learning Gaps

Primary mitochondrial disease (PMD) is often missed by clinicians due to the broad range of clinical presentations and genetic etiologies. Our recent program “Progressive Myopathy: Could it be a Genetic Mitochondrial Disease?” focused on diagnosing this condition in infants, children, and adults who present with progressive muscle weakness; understanding the diagnostic workup; and manifestations of thymidine kinase 2 (TK2) deficiency.  […]

Read More

The Value of Authentic Patient Voice in Digital Education

Enhancing CME programs with patient voice is an effective strategy for helping providers retain what they’ve learned. National Organization of Rare Disorders Chief Medical and Science Officer Edward Neilan, MD, PhD noted, “when it comes to educational materials, hearing from the patient makes it much more memorable, much more engaging, and a longer lasting educational contribution.”  […]

Read More

2022 ASCO Annual Meeting Supplemental Digital Oncology Resources

The 2022 ASCO Annual Meeting is a place where cutting-edge research spanning all major disease sites comes together so leaders in the field can stay up-to-date on clinical trials, the latest findings, and global perspectives on oncology innovations. We are especially excited to have two accepted e-abstracts at the 2022 ASCO Annual Meeting that demonstrate the […]

Read More

Presenting Education Outcomes at ASPHO 2022

We’re pleased to share that the conference has accepted our poster abstract “Impact of Patient-Provider Initiative on Treatment of Pediatric Neuroblastoma” at the 2022 American Society of Pediatric Hematology/Oncology (ASPHO) Conference brings together hematology/oncology professionals for premier education and networking. […]

Read More

2022 Alliance Industry Summit Supplemental Digital Resources

Poster Presentation The Power of Education to Debunk Myths and Misconceptions about Clinical Trial Participation Among People with Diverse Racial and Ethnic Backgrounds The 2022 Alliance Industry Summit (ASI) will feature our poster about the power of education to debunk myths and misconceptions about clinical trial participation among people from diverse racial and ethnic backgrounds. […]

Read More

CME Palooza Spotlight: Equity in Clinical Trials Is Within Reach: Patient Voices in Medical Education Matter

In our latest collaboration with CME Palooza, we hosted a webinar featuring Jeanne Regnante, Chief Health Equity and Diversity Officer of the lung cancer advocacy organization, LUNGevity, Shawn Feliciano, a patient with MS who has participated in clinical trial research and Sapana Panday, Senior Director of Digital Education at PlatformQ Health. During this conversation the […]

Read More

Go-to Market Strategies for a Successful Drug Launch: Best Practices for Engaging Providers and Patients

A strong pharma product launch can help bolster a drug’s performance over its lifecycle. Most new drugs continue with the revenue trajectory achieved at launch. An analysis by the Deloitte Center for Health Solution found roughly 80 percent of products that met or exceeded initial expectations continued their success rate in subsequent years. That’s why educating physicians quickly in the early months of a product launch delivers a notable advantage. […]

Read More

#ASH21 Day 3 Recap: Ensuring health equity & research findings

Day 3 of the ASH Annual Meeting & Exposition kicked off with a continuation of the Diversity, Health, and Equity track, focusing on changing the tide from paternalistic patterns and exclusion of marginalized populations to inclusion of clinical trial design and a “deliberateness” of engaging minority communities from the very start. This important effort to reevaluate the status quo is part of the hematology community’s commitment to ensuring equity and addressing disparities. […]

Read More

#ASH21 Day 1 Recap: Tackling Health Equity and Highlighting New Research Findings

The first day of the highly anticipated 63rd ASH Annual Meeting & Exposition kicked off with a new track focused on diversity, health, and equity. As the world’s largest professional society committed to conquering blood diseases, ASH is building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences.  […]

Read More

End of Year Infographic: A digital peer-to-peer education model designed to drive provider awareness, engagement and adoption

Early education of the marketplace is crucial for a successful pharmaceutical product launch. We’re pleased to share how our peer-to-peer education model drives more efficient provider education as well as alignment with the field force.     Download the PDF Version: 2021-Infographic-DS Be sure to check out our other End of Year Infographics: Continuing Medical […]

Read More

End of Year Infographic: Empowering patients on their journey to improved confidence and communication

As patients take an increasingly active role in their own care, education plays a central role. Knowledge fosters shared decision making among providers, patients, and their families. We’re pleased to share outcomes from our digital patient education model.   Download the PDF version: 2021-Infographic-Patient.pdf Be sure to check out our other End of Year Infographics: […]

Read More

End of Year Infographic: Fostering a powerful, patient-centric, continuing medical education model

Tracking outcomes is essential to PlatformQ Health education, both as a means to continually enhance engagement and to assess knowledge gaps that support the development of future programming. We’re pleased to share the most significant outcomes across our CME programs and their impact on clinical practice and patient outcomes.   Download the PDF version now: […]

Read More

Addressing the gulf between patient and provider perspectives

Tethered education: Aligning patients and providers  What spurs patients to choose one treatment option over another? What are the hurdles patients face when presented with a newly FDA approved drug? What barriers to change keep physicians from prescribing new treatments?  The practice of shared decision making can help answer these crucial questions. This approach can […]

Read More

NORD Rare Summit 2021: Demonstrating the Need for Education in Rare Conditions Among Providers and Patients

For many people suffering from rare diseases, the diagnostic odyssey is far too long. Nearly 1 in 13 people are living with an undiagnosed condition, and it typically takes five years or longer to receive the correct diagnosis. Consistent clinician and patient education about rare diseases is crucial for helping to reduce time to diagnosis […]

Read More

Alliance Industry Summit Best in Class 2021 – Awarded for a unique outcomes approach that combined quantitative and qualitative methods to incite real change in healthcare

PlatformQ Health received the Best in Class award at the Alliance For Continuing Education in the Health Professions 2021 Virtual Alliance Industry Summit for the outcomes poster, “Unearthing the impact of Urology education through in-depth, qualitative interviews.” […]

Read More

A Changing World: A Look Back on 2020

In 2020, PlatformQ Health’s mission to improve health outcomes through trusted digital education did not waver. We are grateful to be a steady hand for our partners, HCP and patient learners, and supporters, providing continuity through seamless shifts into the digital world. Digital education is at the heart of our past and current success, and our ability to adapt and innovate is a critical component of our future-focused orientation. […]

Read More

NORD, FDA, and CDC Leaders Provide Rare Disease Community COVID-19 Vaccine Education Leveraging PlatformQ Health’s CONDUIT Solution  

While the COVID-19 pandemic has been socially and economically devastating for us all, the rare-disease community faces a unique set of challenges. Seeking to address these challenges, the National Organization for Rare Disorders (NORD) leveraged Conduit – PlatformQ Health’s proprietary engagement platform – to host the webinar, COVID-19 Vaccines Update: FDA and CDC Leaders Address the Rare Disease Community.  […]

Read More

PlatformQ Health, the American Migraine Foundation and the National Headache Foundation collaborate on a new tethered digital educational program

PlatformQ Health is launching, “Aligned Health Care Provider and Patient Education on Calcitonin Gene-Related Peptide-Targeted Treatment of Migraine,” a new digital tethered education program, produced in collaboration with the American Migraine Foundation and the National Headache Foundation on January 22, 2021. […]

Read More

AAAAI & AAD 2020 Annual Meetings: Education on Atopic Dermatitis Activates Knowledge and Behavioral Shifts among Caregivers, Patients and HCPs

PlatformQ Health is excited to share results from an HCP and patient education initiative that were to be presented as two uniquely focused poster presentations at the American Academy of Allergy, Asthma and Immunology’s Annual Meeting and the American Academy of Dermatology’s 2020 Annual Meeting, respectively. […]

Read More